» Articles » PMID: 30340078

Clinical Utility of Susceptibility-weighted MR Sequence for the Evaluation of Uterine Sarcomas

Overview
Journal Clin Imaging
Publisher Elsevier
Specialty Radiology
Date 2018 Oct 20
PMID 30340078
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: High intensity intra-tumoral hemorrhagic necrosis on T1-weighted images is a suggestive finding for uterine sarcomas, however, the reported prevalence varies. The purpose of this study is to evaluate the capability of susceptibility-weighted MR sequences (SWS) for the diagnosis of uterine sarcomas.

Materials And Methods: MR imaging of surgically proven 10 uterine sarcomas and 24 benign leiomyomas were retrospectively evaluated for the presence of high intensity areas on T1-weighted images and signal voids on SWS (T2 star-weighted angiography: SWAN).

Results: High intensity areas on T1-weighted images and signal voids on SWS were observed in 40% and 100% of sarcomas, whereas 0% and 4% of leiomyomas, respectively. The accuracy, sensitivity, and specificity for T1-weighted images were 82%, 40%, and 100%, and for SWS were 97%, 100%, and 96%, respectively.

Conclusion: The demonstration of intra-tumoral hemorrhage in patients suspected with uterine sarcomas by SWS may provide valuable diagnostic findings.

Citing Articles

Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels.

Suzuki A, Kido A, Matsuki M, Kotani Y, Murakami K, Yamanishi Y Diagnostics (Basel). 2023; 13(8).

PMID: 37189505 PMC: 10137865. DOI: 10.3390/diagnostics13081404.


Sonographic and Magnetic Resonance Characteristics of Gynecological Sarcoma.

Camponovo C, Neumann S, Zosso L, Mueller M, Raio L Diagnostics (Basel). 2023; 13(7).

PMID: 37046441 PMC: 10092971. DOI: 10.3390/diagnostics13071223.


MR Imaging Findings of Uterine Adenomatoid Tumors.

Takeuchi M, Matsuzaki K, Bando Y, Harada M Magn Reson Med Sci. 2023; 23(2):127-135.

PMID: 36697028 PMC: 11024713. DOI: 10.2463/mrms.mp.2022-0067.


Imaging in translational cancer research.

Kurz F, Schlemmer H Cancer Biol Med. 2022; 19(11).

PMID: 36476372 PMC: 9724222. DOI: 10.20892/j.issn.2095-3941.2022.0677.


Advances in the Preoperative Identification of Uterine Sarcoma.

Liu J, Wang Z Cancers (Basel). 2022; 14(14).

PMID: 35884577 PMC: 9318633. DOI: 10.3390/cancers14143517.